Identification of Novel Functional Inhibitors of Acid Sphingomyelinase
Open accessThe DOI matches its Crossref record; 121 of the 121 references it cites were found in a registry or an index.
Abstract
We describe a hitherto unknown feature for 27 small drug-like molecules, namely functional inhibition of acid sphingomyelinase (ASM). These entities named FIASMAs (Functional Inhibitors of Acid SphingoMyelinAse), therefore, can be potentially used to treat diseases associated with enhanced activity of ASM, such as Alzheimer's disease, major depression, radiation- and chemotherapy-induced apoptosis and endotoxic shock syndrome. Residual activity of ASM measured in the presence of 10 µM drug concentration shows a bimodal distribution; thus the tested drugs can be classified into two groups with lower and higher inhibitory activity. All FIASMAs share distinct physicochemical properties in showing lipophilic and weakly basic properties. Hierarchical clustering of Tanimoto coefficients revealed that FIASMAs occur among drugs of various chemical scaffolds. Moreover, FIASMAs more frequently violate Lipinski's Rule-of-Five than compounds without effect on ASM. Inhibition of ASM appears to be associated with good permeability across the blood-brain barrier. In the present investigation, we developed a novel structure-property-activity relationship by using a random forest-based binary classification learner. Virtual screening revealed that only six out of 768 (0.78%) compounds of natural products functionally inhibit ASM, whereas this inhibitory activity occurs in 135 out of 2028 (6.66%) drugs licensed for medical use in humans.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Breiman, L. (2001) · Machine Learning · doi:10.1023/a:1010933404324 · Cited by 133,538
Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing
Benjamini, Y., & Hochberg, Y. (1995) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1995.tb02031.x · Cited by 109,482 · cited 3×
“Within this contingency table, the multiple test correction (Benjamini-Hochberg [90]) identified therapeutic groups with a significantly enriched fraction of FIASMAs [132].”
MethodInfluentialData Mining: Practical Machine Learning Tools and Techniques
(2011) · Elsevier eBooks · doi:10.1016/c2009-0-19715-5 · Cited by 25,437
Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00129-0 · Cited by 18,139
Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (1997) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(96)00423-1 · Cited by 11,385
Witten, I. H. (2008) · Cited by 9,143
Wrappers for feature subset selection
Kohavi, R., & John, G. H. (1997) · Artificial Intelligence · doi:10.1016/s0004-3702(97)00043-x · Cited by 8,947 · cited 1×
“For the hypothesis-free selection, attributes were chosen by at least one of the following methods: wrapper [102], relief [103,104], correlation based weighting, information gain weighting, standard deviation based weighting, support vector machine based weighting and rule based weighting.”
MethodMolecular Mechanisms of Depression: Perspectives on New Treatment Strategies
Lang, U. E., & Borgwardt, S. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350094 · Cited by 8,475
An introduction to variable and feature selection
GuyonIsabelle, & ElisseeffAndré (2003) · Journal of Machine Learning Research · doi:10.5555/944919.944968 · Cited by 7,715
An Introduction to Variable and Feature Selection.
Guyon, I., & Elisseeff, A. (2003) · Cited by 6,576
A review of feature selection techniques in bioinformatics
Saeys, Y., Inza, I., & Larrañaga, P. (2007) · Bioinformatics · doi:10.1093/bioinformatics/btm344 · Cited by 5,244
Handbook of Molecular Descriptors
Todeschini, R., & Consonni, V. (2000) · Methods and Principles in Medicinal Chemistry · doi:10.1002/9783527613106 · Cited by 4,107
Random Forest: A Classification and Regression Tool for Compound Classification and QSAR Modeling
Svetnik, V., Liaw, A., Tong, C., Culberson, J. C., Sheridan, R. P., & Feuston, B. P. (2003) · Journal of Chemical Information and Computer Sciences · doi:10.1021/ci034160g · Cited by 3,573 · cited 1×
“In contrast to a simple decision tree learner, random forest learners are more resistant against overfitting and result in more stable models, meaning that small changes in the training set do not lead to completely different models [113,114], and lead to better predictivity on unknown compounds.”
Estimating attributes: Analysis and extensions of RELIEF
Kononenko, I. (1994) · Lecture Notes in Computer Science · doi:10.1007/3-540-57868-4_57 · Cited by 2,958 · cited 1×
“For the hypothesis-free selection, attributes were chosen by at least one of the following methods: wrapper [102], relief [103,104], correlation based weighting, information gain weighting, standard deviation based weighting, support vector machine based weighting and rule based weighting.”
MethodThe cost of dichotomising continuous variables
Altman, D. G., & Royston, P. (2006) · BMJ · doi:10.1136/bmj.332.7549.1080 · Cited by 2,688
Estimation of the Youden Index and its Associated Cutoff Point
Fluss, R., Faraggi, D., & Reiser, B. (2005) · Biometrical Journal · doi:10.1002/bimj.200410135 · Cited by 2,608 · cited 1×
“Because of the unbalanced class distribution, the Youden-Index [109–111] (sensitivity + specificity21) was chosen as primary performance measure evaluating models based on twoclass learners.”
MethodNährlich, L., Mainz, J. G., Adams, C., Engel, C., Herrmann, G., Icheva, V., Lauer, J., Deppisch, C., Wirth, A., Unger, K., et al. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350071 · Cited by 2,525
Self-citationTropsha, A., Gramatica, P., & Gombar, V. K. (2003) · QSAR & Combinatorial Science · doi:10.1002/qsar.200390007 · Cited by 2,188 · cited 2×
“used the response permutation test, also known as Y-scrambling [59–61,115] to detect random effects.”
MethodDe Duve, C., De Barsy, T., Poole, B., Trouet, A., Tulkens, P., & Van Hoof, F. (1974) · Biochemical Pharmacology · doi:10.1016/0006-2952(74)90174-9 · Cited by 1,901
The feature selection problem: traditional methods and a new algorithm
Kira, K., & Rendell, L. A. (1992) · National Conference on Artificial Intelligence · Cited by 1,897
Suppression of ceramide-mediated programmed cell death by sphingosine-1-phosphate
Cuvillier, O., Pirianov, G., Kleuser, B., Vanek, P. G., Coso, O. A., Gutkind, J. S., & Spiegel, S. (1996) · Nature · doi:10.1038/381800a0 · Cited by 1,529 · cited 1×
“This dynamic balance between ceramide and sphingosine-1-phosphate is referred to as the ‘‘ceramide/sphingosine-1phosphate rheostat’’ [17–19], maintaining the balance between growth and cell death.”
BackgroundPubChem: a public information system for analyzing bioactivities of small molecules
Wang, Y., Xiao, J., Suzek, T. O., Zhang, J., Wang, J., & Bryant, S. H. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkp456 · Cited by 1,467 · cited 1×
“Molecular structures were obtained from the PubChem-Project page [87,88] (Table S1).”
MethodProgrammed Cell Death and the Control of Cell Survival: Lessons from the Nervous System
Raff, M. C., Barres, B. A., Burne, J. F., Coles, H. S., Ishizaki, Y., & Jacobson, M. D. (1993) · Science · doi:10.1126/science.8235590 · Cited by 1,460 · cited 1×
“Therefore, ASM inhibitors hold promise for a number of new clinical therapies and might be used to prevent apoptosis and other negative effects occurring in different disease states such as in ischemia, stroke, Alzheimer’s dementia, Parkinson’s disease, Huntington’s chorea, and of certain infections, in endotoxemia, a…”
BackgroundEncyclopedia of Artificial Intelligence
(2009) · IGI Global eBooks · doi:10.4018/978-1-59904-849-9 · Cited by 1,396
Endothelial Apoptosis as the Primary Lesion Initiating Intestinal Radiation Damage in Mice
Paris, F., Fuks, Z., Kang, A., Capodieci, P., Juan, G., Ehleiter, D., Haimovitz-Friedman, A., Cordon-Cardo, C., & Kolesnick, R. (2001) · Science · doi:10.1126/science.1060191 · Cited by 1,283 · cited 1×
“Genetic inactivation of ASM prevents this toxicity [74].”
BackgroundYALE: rapid prototyping for complex data mining tasks
Mierswa, I., Wurst, M., Klinkenberg, R., Scholz, M., & Euler, T. (2006) · Proceedings of the 12th ACM SIGKDD international conference on Knowledge discovery and data mining · doi:10.1145/1150402.1150531 · Cited by 1,010 · cited 1×
“Data pre-processing was performed using RapidMiner 5.1”
InfluentialSimilarity-based virtual screening using 2D fingerprints
Willett, P. (2006) · Drug Discovery Today · doi:10.1016/j.drudis.2006.10.005 · Cited by 849 · cited 2×
“Relative structural diversity of the set of compounds used In order to estimate the structural diversity of our investigated sets of compounds, we performed a hierarchical clustering based on Tanimoto coefficients [67] for fingerprints based on tagged graph triangles (TGT) [116,117].”
MethodKelder, J., Grootenhuis, P. D. J., Bayada, D. M., Delbressine, L. P. C., & Ploemen, J.-P. (1999) · Pharmaceutical Research · doi:10.1023/a:1015040217741 · Cited by 813 · cited 1×
“LogBB values were compiled from a number of published papers [58,118–128].”
MethodLevin, V. A. (1980) · Journal of Medicinal Chemistry · doi:10.1021/jm00180a022 · Cited by 813 · cited 3×
“Furthermore, we used an MW-based correction of logP-values (logP2K*logWeight [56,57]).”
MethodSantana, P., Peña, L. A., Haimovitz-Friedman, A., Martin, S., Green, D., McLoughlin, M., Cordon-Cardo, C., Schuchman, E. H., Fuks, Z., & Kolesnick, R. (1996) · Cell · doi:10.1016/s0092-8674(00)80091-4 · Cited by 797 · cited 1×
“Although these enzymes and an existing de novo synthesis pathway are alternative mechanisms for ceramide generation, activation of ASM itself has been proven to be critical for some cellular responses, such as apoptosis induced by reactive oxygen and nitrogen species [3], chemotherapy drugs such as cisplatin [8], bact…”
BackgroundStudies in Subjects with Long-Term Nonprogressive Human Immunodeficiency Virus Infection
Pantaleo, G., Menzo, S., Vaccarezza, M., Graziosi, C., Cohen, O. J., Demarest, J. F., Montefiori, D., Orenstein, J. M., Fox, C., Schrager, L. K., et al. (1995) · New England Journal of Medicine · doi:10.1056/nejm199501263320402 · Cited by 730 · cited 2×
“Interestingly, HIV-1 infected long-term nonprogressors have less elevated lymphocyte-associated ceramide than subjects with evolving AIDS [76], which is paralleled by a lower frequency of apoptotic CD4 and CD8 cells in long-term nonprogressors compared to patients with AIDS [77].”
BackgroundCeramide in the eukaryotic stress response
Hannun, Y. A., & Luberto, C. (2000) · Trends in Cell Biology · doi:10.1016/s0962-8924(99)01694-3 · Cited by 727 · cited 1×
“CD95 ligands and cytokines such as tumor necrosis factor-a, interleukin-1 and interferon-c but also other stimuli including oxidative stress, reactive oxygen and nitrogen species, ionizing radiation, UV-C radiation, heat shock and other agents of stress, injury or infections by HIV or bacteria have been shown to stimu…”
BackgroundSphingolipid metabolism and cell growth regulation
Spiegel, S., & Merrill, A. H. (1996) · The FASEB Journal · doi:10.1096/fasebj.10.12.8903509 · Cited by 715 · cited 1×
“This dynamic balance between ceramide and sphingosine-1-phosphate is referred to as the ‘‘ceramide/sphingosine-1phosphate rheostat’’ [17–19], maintaining the balance between growth and cell death.”
BackgroundThe complex life of simple sphingolipids
Futerman, A. H., & Hannun, Y. A. (2004) · EMBO reports · doi:10.1038/sj.embor.7400208 · Cited by 659 · cited 1×
“While the biological function of sphingosine is largely unknown, sphingosine-1-phosphate has been shown to be involved in cellular differentiation, proliferation and cell migration [12–16].”
BackgroundCD95 Signaling via Ceramide-rich Membrane Rafts
Grassme, H., Jekle, A., Riehle, A., Schwarz, H., Berger, J., Sandhoff, K., Kolesnick, R., & Gulbins, E. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m101207200 · Cited by 636 · cited 1×
“CD95 ligands and cytokines such as tumor necrosis factor-a, interleukin-1 and interferon-c but also other stimuli including oxidative stress, reactive oxygen and nitrogen species, ionizing radiation, UV-C radiation, heat shock and other agents of stress, injury or infections by HIV or bacteria have been shown to stimu…”
BackgroundSelf-citationHan, X., M. Holtzman, D., W. McKeel, D., Kelley, J., & Morris, J. C. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.00997.x · Cited by 626 · cited 1×
“Reports have been published of aberrant activation of ASM and/or altered levels of ceramide, for instance, for several psychiatric and neurological disorders such as major depression [23–25], morphine antinociceptive tolerance [26], Alzheimer’s disease [27–29], spinal cord injury [30] and seizure disorder [31].”
BackgroundModelling of the blood–brain barrier in drug discovery and development
Cecchelli, R., Berezowski, V., Lundquist, S., Culot, M., Renftel, M., Dehouck, M.-P., & Fenart, L. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2368 · Cited by 618 · cited 1×
“traffic across the BBB to take the transcellular route [64].”
BackgroundChemometric methods in molecular design
Waterbeemd, H. V. D. (1995) · Medical Entomology and Zoology · Cited by 561
Sphingosine 1-Phosphate, a Key Cell Signaling Molecule
Spiegel, S., & Milstien, S. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.r200007200 · Cited by 555 · cited 1×
“While the biological function of sphingosine is largely unknown, sphingosine-1-phosphate has been shown to be involved in cellular differentiation, proliferation and cell migration [12–16].”
BackgroundTeichgräber, V., Ulrich, M., Endlich, N., Riethmüller, J., Wilker, B., De Oliveira–Munding, C. C., van Heeckeren, A. M., Barr, M. L., von Kürthy, G., Schmid, K. W., et al. (2008) · Nature Medicine · doi:10.1038/nm1748 · Cited by 542
Self-citationHost defense against Pseudomonas aeruginosa requires ceramide-rich membrane rafts
Grassmé, H., Jendrossek, V., Riehle, A., von Kürthy, G., Berger, J., Schwarz, H., Weller, M., Kolesnick, R., & Gulbins, E. (2003) · Nature Medicine · doi:10.1038/nm823 · Cited by 536 · cited 1×
“Although these enzymes and an existing de novo synthesis pathway are alternative mechanisms for ceramide generation, activation of ASM itself has been proven to be critical for some cellular responses, such as apoptosis induced by reactive oxygen and nitrogen species [3], chemotherapy drugs such as cisplatin [8], bact…”
BackgroundSelf-citationComparing the predictive accuracy of models using a simple randomization test
van der Voet, H. (1994) · Chemometrics and Intelligent Laboratory Systems · doi:10.1016/0169-7439(94)85050-x · Cited by 522
Deregulation of sphingolipid metabolism in Alzheimer’s disease
He, X., Huang, Y., Li, B., Gong, C.-X., & Schuchman, E. H. (2010) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2008.05.010 · Cited by 516 · cited 1×
“Reports have been published of aberrant activation of ASM and/or altered levels of ceramide, for instance, for several psychiatric and neurological disorders such as major depression [23–25], morphine antinociceptive tolerance [26], Alzheimer’s disease [27–29], spinal cord injury [30] and seizure disorder [31].”
Background(2015) · Springer eBooks · doi:10.1007/978-1-4899-7488-4 · Cited by 476
Breaking up is Hard to Do: The Heartbreak of Dichotomizing Continuous Data
Streiner, D. L. (2002) · The Canadian Journal of Psychiatry · doi:10.1177/070674370204700307 · Cited by 433 · cited 1×
“Usually, dichotomizing continuous variables results in a number of statistical problems, including a loss of statistical power to detect a relation between a variable and outcome [53–55].”
BackgroundThe metabolism of sphingomyelin. II. Evidence of an enzymatic deficiency in Niemann-Pick diseae.
Brady, R. O., Kanfer, J. N., Mock, M. B., & Fredrickson, D. S. (1966) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.55.2.366 · Cited by 427 · cited 1×
“ASM is best known for its involvement in Niemann-Pick disease, a lysosomal storage disease due to an inherited enzyme deficiency [20].”
BackgroundRole of the Sphingosine-1-Phosphate Receptor EDG-1 in PDGF-Induced Cell Motility
Hobson, J. P., Rosenfeldt, H. M., Barak, L. S., Olivera, A., Poulton, S., Caron, M. G., Milstien, S., & Spiegel, S. (2001) · Science · doi:10.1126/science.1057559 · Cited by 426 · cited 1×
“While the biological function of sphingosine is largely unknown, sphingosine-1-phosphate has been shown to be involved in cellular differentiation, proliferation and cell migration [12–16].”
BackgroundLipopolysaccharide Induces Disseminated Endothelial Apoptosis Requiring Ceramide Generation
Haimovitz-Friedman, A., Cordon-Cardo, C., Bayoumy, S., Garzotto, M., McLoughlin, M., Gallily, R., Edwards, C. K., Schuchman, E. H., Fuks, Z., & Kolesnick, R. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.11.1831 · Cited by 408 · cited 1×
“The endotoxic shock syndrome, which is characterized by systemic inflammation, multiple organ damage, circulatory collapse and death, is caused by disseminated endothelial apoptosis sequentially mediated by TNF and ceramide generation [78].”
BackgroundFAS-induced apoptosis is mediated via a ceramide-initiated RAS signaling pathway
Gulbins, E., Bissonnette, R., Mahboubi, A., Martin, S., Nishloka, W., Brunner, T., Baier, G., Baler-Bltterlich, G., Byrd, C., Lang, F., et al. (1995) · Immunity · doi:10.1016/1074-7613(95)90142-6 · Cited by 399
Self-citationThe therapeutic potential of modulating the ceramide/sphingomyelin pathway
Kolesnick, R. (2002) · Journal of Clinical Investigation · doi:10.1172/jci16127 · Cited by 393 · cited 1×
“Therefore, ASM inhibitors hold promise for a number of new clinical therapies and might be used to prevent apoptosis and other negative effects occurring in different disease states such as in ischemia, stroke, Alzheimer’s dementia, Parkinson’s disease, Huntington’s chorea, and of certain infections, in endotoxemia, a…”
BackgroundBlood-Brain Barrier Permeation: Molecular Parameters Governing Passive Diffusion
Fischer, H., Gottschlich, R., & Seelig, A. (1998) · Journal of Membrane Biology · doi:10.1007/s002329900434 · Cited by 371 · cited 12×
“Data on passive diffusion across the blood-brain barrier The most common value describing permeability across the blood-brain barrier (BBB) is the logBB.”
BackgroundInfluentialKornhuber, J., Tripal, P., Reichel, M., Mühle, C., Rhein, C., Muehlbacher, M., Groemer, T. W., & Gulbins, E. (2010) · Cellular Physiology and Biochemistry · doi:10.1159/000315101 · Cited by 354 · cited 3×
“These entities named FIASMAs (Functional Inhibitors of Acid SphingoMyelinAse), therefore, can be potentially used to treat diseases associated with enhanced activity of ASM, such as Alzheimer’s disease, major depression, radiation- and chemotherapy-induced apoptosis and endotoxic shock syndrome.”
BackgroundInfluentialSelf-citationThe therapeutic potential of modulating the ceramide/sphingomyelin pathway
Kolesnick, R. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0216127 · Cited by 351
Statistical Validation of QSAR Results
Wold, S., Eriksson, L., & Clementi, S. (1995) · Methods and Principles in Medicinal Chemistry · doi:10.1002/9783527615452.ch5 · Cited by 334 · cited 1×
“used the response permutation test, also known as Y-scrambling [59–61,115] to detect random effects.”
MethodComputational approaches to the prediction of the blood–brain distribution
Norinder, U., & Haeberlein, M. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00005-4 · Cited by 305 · cited 4×
“logPACD10_minus_O_N LogP – number of oxygen and nitrogen atoms [134]”
BackgroundInfluentialPAF-mediated pulmonary edema: a new role for acid sphingomyelinase and ceramide
Göggel, R., Winoto-Morbach, S., Vielhaber, G., Imai, Y., Lindner, K., Brade, L., Brade, H., Ehlers, S., Slutsky, A. S., Schütze, S., et al. (2004) · Nature Medicine · doi:10.1038/nm977 · Cited by 291 · cited 1×
“Alzheimer’s disease, major depression, inflammatory bowel disease [42], liver cell death and anaemia occurring in Wilson disease, and pulmonary edema in acute lung injury [82].”
BackgroundSelf-citationRagland, D. R. (1992) · Epidemiology · doi:10.1097/00001648-199209000-00009 · Cited by 280 · cited 1×
“Usually, dichotomizing continuous variables results in a number of statistical problems, including a loss of statistical power to detect a relation between a variable and outcome [53–55].”
BackgroundRoles and regulation of secretory and lysosomal acid sphingomyelinase
Jenkins, R. W., Canals, D., & Hannun, Y. A. (2009) · Cellular Signalling · doi:10.1016/j.cellsig.2009.01.026 · Cited by 278 · cited 1×
“Furthermore, in contrast to other sphingomyelinases, ASM activity is tightly regulated [11].”
BackgroundPhysiological and pathophysiological aspects of ceramide
Gulbins, E., & Li, P. L. (2006) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00416.2005 · Cited by 248 · cited 1×
“Therefore, ASM inhibitors hold promise for a number of new clinical therapies and might be used to prevent apoptosis and other negative effects occurring in different disease states such as in ischemia, stroke, Alzheimer’s dementia, Parkinson’s disease, Huntington’s chorea, and of certain infections, in endotoxemia, a…”
BackgroundSelf-citationThe Metabolism of Sphingomyelin
Kanfer, J. N., Young, O. M., Shapiro, D., & Brady, R. O. (1966) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)96805-5 · Cited by 248
Hurwitz, R., Ferlinz, K., & Sandhoff, K. (1994) · Biological Chemistry Hoppe-Seyler · doi:10.1515/bchm3.1994.375.7.447 · Cited by 244
Amaratunga, D., Cabrera, J., & Lee, Y.-S. (2008) · Bioinformatics · doi:10.1093/bioinformatics/btn356 · Cited by 228 · cited 1×
“. Features with very low variance were eliminated. Missing values for the most basic pKa-values were substituted by 0, missing most acidic pKa-values were substituted by 15, missing values for k were substituted by 12. Otherwise, we used only molecular descriptors that were available for all compounds and thereby obta…”
MethodKornhuber, J., Tripal, P., Reichel, M., Terfloth, L., Bleich, S., Wiltfang, J., & Gulbins, E. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm070524a · Cited by 223 · cited 11×
“The previously suggested model [52] was now improved in several ways by using advanced molecular descriptors (e.”
BackgroundMethodInfluentialSelf-citationSchwarz, E., Prabakaran, S., Whitfield, P., Major, H., Leweke, F. M., Koethe, D., McKenna, P., & Bahn, S. (2008) · Journal of Proteome Research · doi:10.1021/pr800188y · Cited by 221 · cited 1×
“Reports have been published of aberrant activation of ASM and/or altered levels of ceramide, for instance, for several psychiatric and neurological disorders such as major depression [23–25], morphine antinociceptive tolerance [26], Alzheimer’s disease [27–29], spinal cord injury [30] and seizure disorder [31].”
BackgroundThe selection and use of essential medicines.
Kazembe, P. N., Fannah, J. A., Hoppu, K., Zisovska, E., Pedersen, H., Hill, S., Ondari, C. O., Terlouw, D. J., Mattison, D. R., Zhi-ping, L., et al. (2004) · PubMed · Cited by 215
Smith, E. L., & Schuchman, E. H. (2008) · The FASEB Journal · doi:10.1096/fj.08-108043 · Cited by 213 · cited 1×
“. However, studies using cells derived from Niemann-Pick disease patients or from ASM knock-out mice revealed that the deficiency of this enzyme might also have beneficial consequences, including anti-apoptotic and cytoprotective effcts. In fact, there is increasing evidence that ASM activation and ceramide accumulati…”
BackgroundMalaplate-Armand, C., Florent-Béchard, S., Youssef, I., Koziel, V., Sponne, I., Kriem, B., Leininger-Muller, B., Olivier, J.-L., Oster, T., & Pillot, T. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2006.02.010 · Cited by 213
Yu, Z. F., Nikolova-Karakashian, M., Zhou, D., Cheng, G., Schuchman, E. H., & Mattson, M. P. (2000) · Journal of Molecular Neuroscience · doi:10.1385/jmn:15:2:85 · Cited by 210 · cited 1×
“Several examples are given here: Induction of stroke by experimental ischemia of the brain was shown to correlate with an activation of the ASM and a release of ceramide [71,72].”
BackgroundSphingosine‐1‐Phosphate in Cell Growth and Cell Deatha
SPIEGEL, S., CUVILLIER, O., EDSALL, L. C., KOHAMA, T., MENZELEEV, R., OLAH, Z., OLIVERA, A., PIRIANOV, G., THOMAS, D. M., TU, Z., et al. (1998) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1998.tb09658.x · Cited by 203 · cited 1×
“This dynamic balance between ceramide and sphingosine-1-phosphate is referred to as the ‘‘ceramide/sphingosine-1phosphate rheostat’’ [17–19], maintaining the balance between growth and cell death.”
BackgroundQSAR Modeling of the Blood–Brain Barrier Permeability for Diverse Organic Compounds
Zhang, L., Zhu, H., Oprea, T. I., Golbraikh, A., & Tropsha, A. (2008) · Pharmaceutical Research · doi:10.1007/s11095-008-9609-0 · Cited by 201 · cited 1×
“vsa_pol is an approximation to the sum of van-der-Waals surface areas of polar atoms and has been described to predict BBB permeability [58].”
Correlation and prediction of a large blood–brain distribution data set—an LFER study
Platts, J. A., Abraham, M. H., Zhao, Y. H., Hersey, A., Ijaz, L., & Butina, D. (2001) · European Journal of Medicinal Chemistry · doi:10.1016/s0223-5234(01)01269-7 · Cited by 201 · cited 1×
“LogBB values were compiled from a number of published papers [58,118–128].”
MethodKölzer, M., Werth, N., & Sandhoff, K. (2004) · FEBS Letters · doi:10.1016/s0014-5793(04)00033-x · Cited by 198 · cited 1×
“This accumulation of desipramine 168 results in detachment of the ASM from the inner lysosomal membrane [50] and its subsequent inactivation, probably by proteolytic degradation [51].”
BackgroundBradbury, M. (1993) · Experimental Physiology · doi:10.1113/expphysiol.1993.sp003698 · Cited by 191
High activity of acid sphingomyelinase in major depression
Kornhuber, J., Medlin, A., Bleich, S., Jendrossek, V., Henkel, A. W., Wiltfang, J., & Gulbins, E. (2005) · Journal of Neural Transmission · doi:10.1007/s00702-005-0374-5 · Cited by 173 · cited 1×
“Furthermore, ASM could play a key role in the pathophysiology of depression and in the action of antidepressant drugs [23].”
BackgroundSelf-citationToman, R. E., Payne, S. G., Watterson, K. R., Maceyka, M., Lee, N. H., Milstien, S., Bigbee, J. W., & Spiegel, S. (2004) · The Journal of Cell Biology · doi:10.1083/jcb.200402016 · Cited by 173 · cited 1×
“While the biological function of sphingosine is largely unknown, sphingosine-1-phosphate has been shown to be involved in cellular differentiation, proliferation and cell migration [12–16].”
BackgroundModeling Blood-Brain Barrier Partitioning Using the Electrotopological State
Rose, K., Hall, L. H., & Kier, L. B. (2002) · Journal of Chemical Information and Computer Sciences · doi:10.1021/ci010127n · Cited by 170 · cited 1×
“LogBB values were compiled from a number of published papers [58,118–128].”
MethodAcid Sphingomyelinase Inhibitors Normalize Pulmonary Ceramide and Inflammation in Cystic Fibrosis
Becker, K. A., Riethmüller, J., Lüth, A., Döring, G., Kleuser, B., & Gulbins, E. (2010) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2009-0174oc · Cited by 164 · cited 1×
“In experimental animals, FIASMAs normalize pulmonary ceramide and inflammation [80].”
BackgroundSelf-citationQualitative prediction of blood–brain barrier permeability on a large and refined dataset
Muehlbacher, M., Spitzer, G. M., Liedl, K. R., & Kornhuber, J. (2011) · Journal of Computer-Aided Molecular Design · doi:10.1007/s10822-011-9478-1 · Cited by 163
Self-citationDrug targeting of sphingolipid metabolism: sphingomyelinases and ceramidases
Canals, D., Perry, D. M., Jenkins, R. W., & Hannun, Y. A. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01279.x · Cited by 162 · cited 1×
“Cationic amphiphilic agents like desipramine, chlorpromazine and chloroquine have been shown to result in both, a reduced level of AC protein and in an increased level of cellular ceramide [84,85].”
BackgroundPrediction Error and Its Estimation for Subset-Selected Models
Roecker, E. B. (1991) · Technometrics · doi:10.1080/00401706.1991.10484873 · Cited by 161
Distinct Roles for Ceramide and Glucosylceramide at Different Stages of Neuronal Growth
Schwarz, A., & Futerman, A. H. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-09-02929.1997 · Cited by 161 · cited 1×
“Ceramide is further metabolized to sphingosine and sphingosine-1-phosphate by acid ceramidase (AC, EC 3.5.1.23) and sphingosine kinases. While the biological function of sphingosine is largely unknown, sphingosine-1-phosphate has been shown to be involved in cellular differentiation, proliferation and cell migration”
BackgroundInfluentialQuantitative modeling of selective lysosomal targeting for drug design
Trapp, S., Rosania, G. R., Horobin, R. W., & Kornhuber, J. (2008) · European Biophysics Journal · doi:10.1007/s00249-008-0338-4 · Cited by 158 · cited 8×
“The lysosomal concentration of each drug was calculated by a previously developed numerical single cell model [49] (see above) and was also used as a molecular descriptor (CLys).”
BackgroundMethodInfluentialSelf-citationCD95-mediated Apoptosis in Vivo Involves Acid Sphingomyelinase
Kirschnek, S., Paris, F., Weller, M., Grassmé, H., Ferlinz, K., Riehle, A., FUKS, Z. Y., Kolesnick, R., & Gulbins, E. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m002957200 · Cited by 153 · cited 3×
“Although these enzymes and an existing de novo synthesis pathway are alternative mechanisms for ceramide generation, activation of ASM itself has been proven to be critical for some cellular responses, such as apoptosis induced by reactive oxygen and nitrogen species [3], chemotherapy drugs such as cisplatin [8], bact…”
BackgroundSelf-citationVilar, S., Chakrabarti, M., & Costanzi, S. (2010) · Journal of Molecular Graphics and Modelling · doi:10.1016/j.jmgm.2010.03.010 · Cited by 149 · cited 1×
“LogBB values were compiled from a number of published papers [58,118–128].”
MethodAbraham, M. H., Ibrahim, A., Zhao, Y. H., & Acree, W. E. (2006) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20595 · Cited by 149 · cited 1×
“LogBB values were compiled from a number of published papers [58,118–128].”
MethodIn Silico Prediction of Blood Brain Barrier Permeability: An Artificial Neural Network Model
Garg, P., & Verma, J. K. (2005) · Journal of Chemical Information and Modeling · doi:10.1021/ci050303i · Cited by 134 · cited 1×
“LogBB values were compiled from a number of published papers [58,118–128].”
MethodNew insights on the use of desipramine as an inhibitor for acid ceramidase
Elojeimy, S. N., Holman, D. H., Liu, X., El-Zawahry, A. M., Villani, M., Cheng, J., Mahdy, A. E. M., Zeidan, Y. H., Bielwaska, A., Hannun, Y. A., et al. (2006) · FEBS Letters · doi:10.1016/j.febslet.2006.07.071 · Cited by 110 · cited 1×
“Cationic amphiphilic agents like desipramine, chlorpromazine and chloroquine have been shown to result in both, a reduced level of AC protein and in an increased level of cellular ceramide [84,85].”
BackgroundSakata, A., Ochiai, T., Shimeno, H., Hikishima, S., Yokomatsu, T., Shibuya, S., Toda, A., Eyanagi, R., & Soeda, S. (2007) · Immunology · doi:10.1111/j.1365-2567.2007.02612.x · Cited by 108 · cited 2×
“Alzheimer’s disease, major depression, inflammatory bowel disease [42], liver cell death and anaemia occurring in Wilson disease, and pulmonary edema in acute lung injury [82].”
BackgroundChanges in bioactive lipids, alkylacylglycerol and ceramide, occur in HIV-infected cells
Veldhoven, P. P. V., Matthews, T. J., Bolognesi, D. P., & Bell, R. M. (1992) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(05)81480-9 · Cited by 107
Liu, R., Sun, H., & So, S. (2001) · Journal of Chemical Information and Computer Sciences · doi:10.1021/ci010290i · Cited by 104
A simple model for the prediction of blood–brain partitioning
Fehér, M., Sourial, E., & Schmidt, J. M. (2000) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(00)00422-1 · Cited by 104 · cited 1×
“I3 +1 for amines, 21 for acids, otherwise 0 [136]”
Apoptosis modulators in the therapy of neurodegenerative diseases
Deigner, H., Haberkorn, U., & Kinscherf, R. (2000) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.9.4.747 · Cited by 103 · cited 1×
“Therefore, ASM inhibitors hold promise for a number of new clinical therapies and might be used to prevent apoptosis and other negative effects occurring in different disease states such as in ischemia, stroke, Alzheimer’s dementia, Parkinson’s disease, Huntington’s chorea, and of certain infections, in endotoxemia, a…”
BackgroundCheminformatics approaches to analyze diversity in compound screening libraries
Akella, L. B., & DeCaprio, D. (2010) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2010.03.017 · Cited by 95
Castillo, S. S., Levy, M., Thaikoottathil, J., & Goldkorn, T. (2007) · Experimental Cell Research · doi:10.1016/j.yexcr.2007.04.002 · Cited by 94 · cited 1×
“Although these enzymes and an existing de novo synthesis pathway are alternative mechanisms for ceramide generation, activation of ASM itself has been proven to be critical for some cellular responses, such as apoptosis induced by reactive oxygen and nitrogen species [3], chemotherapy drugs such as cisplatin [8], bact…”
BackgroundCeramide pathways modulate ethanol‐induced cell death in astrocytes
Pascual, M., Valles, S. L., Renau‐Piqueras, J., & Guerri, C. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.02130.x · Cited by 87 · cited 1×
“Furthermore, the ethanol-induced neuronal cell death is mediated, at least in part, by activation of ASM and generation of ceramide [73].”
BackgroundBenchmarking of QSAR Models for Blood-Brain Barrier Permeation
Konovalov, D. A., Coomans, D. H., Deconinck, E., & Heyden, Y. V. (2007) · Journal of Chemical Information and Modeling · doi:10.1021/ci700100f · Cited by 86 · cited 1×
“LogBB values were compiled from a number of published papers [58,118–128].”
MethodJin, S., Yi, F., Zhang, F., Poklis, J. L., & Li, P. (2008) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.108.172478 · Cited by 82 · cited 1×
“Fusion of secretory lysosomes with the cell surface and translocation of lysosomal ASM onto the outer leaflet of the cell membrane plays an important role during stress response [1].”
BackgroundGerebtzoff, G., & Seelig, A. (2006) · Journal of Chemical Information and Modeling · doi:10.1021/ci0600814 · Cited by 82 · cited 1×
“It has previously been suggested that the lowest cross-sectional area of a molecule perpendicular to the amphiphilic axis determines the insertion of a molecule into a biomembrane and thereby its passive diffusion across the BBB [93,94].”
BackgroundPost Hoc Pair-Wise Comparisons for the Chi-Square Test of Homogeneity of Proportions
Cox, M. K., & Key, C. H. (1993) · Educational and Psychological Measurement · doi:10.1177/0013164493053004008 · Cited by 80 · cited 1×
“Within this contingency table, the multiple test correction (Benjamini-Hochberg [90]) identified therapeutic groups with a significantly enriched fraction of FIASMAs [132].”
MethodIonization-Specific Prediction of Blood–Brain Permeability
Lanevskij, K., Japertas, P., Didžiapetris, R., & Petrauskas, A. A. (2008) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21405 · Cited by 77 · cited 4×
“Furthermore, we used an MW-based correction of logP-values (logP2K*logWeight [56,57]).”
BackgroundMethodInfluentialSuperDrug: a conformational drug database
Goede, A., Dunkel, M., Mester, N., Frömmel, C., & Preißner, R. (2005) · Computer applications in the biosciences · doi:10.1093/bioinformatics/bti295 · Cited by 76 · cited 1×
“was developed in the early 1970s and provides a comprehensive and logical classification system for categorizing pharmaceutical ingredients approved for medical use in humans. While the first level indicates the main anatomical target of the compound, the second level codes for the pharmacologically-relevant therapeut…”
MethodKornhuber, J., Retz, W., & Riederer, P. F. (1995) · PubMed · Cited by 75
Self-citationNdengele, M. M., Cuzzocrea, S., Masini, E., Vinci, M. C., Esposito, E., Muscoli, C., Petrusca, D. N., Mollace, V., Mazzon, E., Li, D., et al. (2008) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.108.146290 · Cited by 74 · cited 1×
“Reports have been published of aberrant activation of ASM and/or altered levels of ceramide, for instance, for several psychiatric and neurological disorders such as major depression [23–25], morphine antinociceptive tolerance [26], Alzheimer’s disease [27–29], spinal cord injury [30] and seizure disorder [31].”
BackgroundRamamurthi, N., & Gunturi, S. B. (2005) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2005.01.061 · Cited by 72 · cited 1×
“LogBB values were compiled from a number of published papers [58,118–128].”
MethodBush, W. S., Edwards, T. L., DUDEK, S. M., McKinney, B. A., & Ritchie, M. D. (2008) · BMC Bioinformatics · doi:10.1186/1471-2105-9-238 · Cited by 72 · cited 1×
“Because of the unbalanced class distribution, the Youden-Index [109–111] (sensitivity + specificity21) was chosen as primary performance measure evaluating models based on twoclass learners.”
MethodThe role of ceramide in major depressive disorder
Kornhuber, J., Reichel, M., Tripal, P., Groemer, T. W., Henkel, A. W., Mühle, C., & Gulbins, E. (2009) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-009-0061-x · Cited by 71 · cited 1×
“Reports have been published of aberrant activation of ASM and/or altered levels of ceramide, for instance, for several psychiatric and neurological disorders such as major depression [23–25], morphine antinociceptive tolerance [26], Alzheimer’s disease [27–29], spinal cord injury [30] and seizure disorder [31].”
BackgroundSelf-citationPhosphatidylinositol-3,5-Bisphosphate Is a Potent and Selective Inhibitor of Acid Sphingomyelinase
Kölzer, M., Arenz, C., Ferlinz, K., Werth, N., Schulze, H., Klingenstein, R., & Sandhoff, K. (2003) · Biological Chemistry · doi:10.1515/bc.2003.144 · Cited by 69 · cited 1×
“These substances include physiological inhibitors of ASM such as phosphatidyl-myoinositol-3,4,5-trisphosphate [40], L-a-phosphatidyl-D-myo-inositol3,5-bisphosphate [41] and non-natural direct inhibitors of ASM, such as SMA-7 [42] and AD2765 [43].”
BackgroundA recursive-partitioning model for blood–brain barrier permeation
Mente, S., & Lombardo, F. (2005) · Journal of Computer-Aided Molecular Design · doi:10.1007/s10822-005-9001-7 · Cited by 65 · cited 1×
“LogBB values were compiled from a number of published papers [58,118–128].”
MethodTherapeutic Efficacy and Safety of Amitriptyline in Patients with Cystic Fibrosis
Riethmüller, J., Anthonysamy, J., Serra, E., Schwab, M., Döring, G., & Gulbins, E. (2009) · Cellular Physiology and Biochemistry · doi:10.1159/000227814 · Cited by 63 · cited 1×
“In a clinical pilot study, amitriptyline 6 led to an improved respiratory function in affected patients [81].”
BackgroundSelf-citationTestai, F. D., Landek‐Salgado, M. A., Goswami, R., Ahmed, M., & Dawson, G. (2004) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2004.02374.x · Cited by 63 · cited 1×
“These substances include physiological inhibitors of ASM such as phosphatidyl-myoinositol-3,4,5-trisphosphate [40], L-a-phosphatidyl-D-myo-inositol3,5-bisphosphate [41] and non-natural direct inhibitors of ASM, such as SMA-7 [42] and AD2765 [43].”
BackgroundCeramide Involvement in Apoptosis and Apoptotic Diseases
Thevissen, K., François, I., Winderickx, J., Pannecouque, C. C., & Cammue, B. P. A. (2006) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/138955706777435643 · Cited by 59
Gilenya (FTY720) inhibits acid sphingomyelinase by a mechanism similar to tricyclic antidepressants
Dawson, G., & Qin, J. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.11.115 · Cited by 56 · cited 1×
“Recently, it has been shown that gilenya (FTY720), a drug licensed for treatment of multiple sclerosis, acts as a FIASMA [83].”
BackgroundAltura, B. M., Gebrewold, A., Zheng, T., & Altura, B. T. (2002) · Brain Research Bulletin · doi:10.1016/s0361-9230(02)00772-4 · Cited by 50
Reverse fingerprinting, similarity searching by group fusion and fingerprint bit importance
Williams, C. (2006) · Molecular Diversity · doi:10.1007/s11030-006-9039-z · Cited by 48 · cited 3×
“Relative structural diversity of the set of compounds used In order to estimate the structural diversity of our investigated sets of compounds, we performed a hierarchical clustering based on Tanimoto coefficients [67] for fingerprints based on tagged graph triangles (TGT) [116,117].”
MethodRecent advances in the immunobiology of ceramide
Pandey, S., Murphy, R. F., & Agrawal, D. K. (2006) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2006.07.009 · Cited by 45 · cited 1×
“Therefore, ASM inhibitors hold promise for a number of new clinical therapies and might be used to prevent apoptosis and other negative effects occurring in different disease states such as in ischemia, stroke, Alzheimer’s dementia, Parkinson’s disease, Huntington’s chorea, and of certain infections, in endotoxemia, a…”
BackgroundPredicting blood–brain barrier penetration from molecular weight and number of polar atoms
Fu, X.-C., Wang, G., Shan, H., Liang, W., & Gao, J. (2008) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2008.05.005 · Cited by 40
CNS Permeability of Drugs Predicted by a Decision Tree
Andrés, C., & Hutter, M. C. (2006) · QSAR & Combinatorial Science · doi:10.1002/qsar.200510200 · Cited by 36 · cited 4×
“QMAXpos Highest positive partial charge [133]”
BackgroundInfluentialDarroch, P. I., Dagan, A., Granot, T., He, X., Gátt, S., & Schuchman, E. H. (2005) · Journal of Lipid Research · doi:10.1194/jlr.m500136-jlr200 · Cited by 29 · cited 1×
“These substances include physiological inhibitors of ASM such as phosphatidyl-myoinositol-3,4,5-trisphosphate [40], L-a-phosphatidyl-D-myo-inositol3,5-bisphosphate [41] and non-natural direct inhibitors of ASM, such as SMA-7 [42] and AD2765 [43].”
BackgroundPurvis, G. D. (2008) · Journal of Computer-Aided Molecular Design · doi:10.1007/s10822-008-9209-4 · Cited by 6 · cited 2×
“si_Weight-Descriptors Size-intensive descriptors [96] using molecular weight as divisor”
BackgroundMethod(1950) · doi:10.1002/1097-0142(1950)3:1<32::aid-cncr2820030106>3.0.co;2-3 · cited 1×
“served to identify high-performing single attributes or attribute combinations. Models were validated by bootstrapping (n = 200). Because of the unbalanced class distribution, the Youden-Index”
MethodCD95-mediated Apoptosis in Vivo Involves Acid Sphingomyelinase
Kirschnek, S., Paris, F., Weller, M., Grassmé, H., Ferlinz, K., Riehle, A., Fuks, Z., Kolesnick, R., & Gulbins, E. (2000) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)61513-9
Self-citation
Cited by
Brain membrane lipids in major depression and anxiety disorders
Müller, C. P., Reichel, M., Mühle, C., Rhein, C., Gulbins, E., & Kornhuber, J. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2014.12.014 · Cited by 308
Self-citationLipids in Psychiatric Disorders and Preventive Medicine
Schneider, M., Levant, B., Reichel, M., Gulbins, E., Kornhuber, J., & Müller, C. P. (2017) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2016.06.002 · Cited by 175
Self-citationSphingolipids in Psychiatric Disorders and Pain Syndromes
Mühle, C., Reichel, M., Gulbins, E., & Kornhuber, J. (2013) · Handbook of Experimental Pharmacology · doi:10.1007/978-3-7091-1511-4_22 · Cited by 58
Self-citationDilna, A., Deepak, K. V., Damodaran, N., Kielkopf, C. S., Kagedal, K., Ollinger, K., & Nath, S. (2021) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2021.166246 · Cited by 51
Metadata
- Authors
- Kornhuber, J., Muehlbacher, M., Trapp, S., Pechmann, S., Friedl, A., Reichel, M., Mühle, C., Terfloth, L., Groemer, T. W., Spitzer, G. M., Liedl, K. R., Gulbins, E., & Tripal, P.
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2011-08-31
- Volume
- 6
- Issue
- 8
- Pages
- e23852
- ISSN
- 1932-6203 (ISSN-L)
- OpenAlex
- W2130218253
- Cited by
- 176
- References
- 121
- FWCI
- 2.70
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.